A detailed history of Old Port Advisors transactions in Sanofi stock. As of the latest transaction made, Old Port Advisors holds 36,732 shares of SNY stock, worth $2.12 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
36,732
Previous 36,224 1.4%
Holding current value
$2.12 Million
Previous $1.76 Billion 1.24%
% of portfolio
0.53%
Previous 0.54%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$45.39 - $50.36 $23,058 - $25,582
508 Added 1.4%
36,732 $1.78 Billion
Q1 2024

Jun 26, 2024

BUY
$45.75 - $52.48 $73,017 - $83,758
1,596 Added 4.61%
36,224 $1.76 Billion
Q4 2023

Jun 26, 2024

BUY
$43.13 - $54.79 $70,301 - $89,307
1,630 Added 4.94%
34,628 $1.72 Billion
Q3 2023

Nov 14, 2023

BUY
$50.95 - $55.2 $80,959 - $87,712
1,589 Added 5.06%
32,998 $1.77 Billion
Q1 2023

Apr 12, 2023

BUY
$45.86 - $54.45 $111,623 - $132,531
2,434 Added 8.4%
31,409 $1.73 Billion
Q4 2022

Jan 11, 2023

BUY
$38.86 - $48.55 $67,460 - $84,282
1,736 Added 6.37%
28,975 $1.4 Billion
Q3 2022

Oct 13, 2022

BUY
$37.22 - $100.5 $42,765 - $115,474
1,149 Added 4.4%
27,239 $1.09 Million
Q2 2022

Jul 08, 2022

BUY
$48.99 - $57.46 $87,545 - $102,681
1,787 Added 7.35%
26,090 $1.31 Million
Q1 2022

Apr 12, 2022

BUY
$48.48 - $53.65 $61,278 - $67,813
1,264 Added 5.49%
24,303 $1.27 Million
Q4 2021

Jan 12, 2022

BUY
$47.07 - $52.35 $44,010 - $48,947
935 Added 4.23%
23,039 $1.14 Million
Q3 2021

Oct 12, 2021

BUY
$47.89 - $53.12 $170,105 - $188,682
3,552 Added 19.15%
22,104 $1.07 Million
Q2 2021

Jul 20, 2021

BUY
$49.36 - $54.25 $561,716 - $617,365
11,380 Added 158.67%
18,552 $971,000
Q1 2021

Apr 08, 2021

BUY
$45.46 - $50.51 $326,039 - $362,257
7,172 New
7,172 $355,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $145B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Old Port Advisors Portfolio

Follow Old Port Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Port Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Old Port Advisors with notifications on news.